THE PCCA BLOG
US$ 25.09
long-term effects of glp-1 drugs Medications Infographic Glucagon-like Receptor-1 agonists for obesity:
Description
However, there are fewer specific studies in PCOS cohorts
The category has also gained global attention for its weight-loss benefits
Researchers found an association between the use of GLP-1s and a higher risk for the condition, called ischemic optic neuropathy, although the risk remained low
( 10.1056/NEJMoa1607141) [DOI] [PubMed] [Google Scholar] 50.Bethel MA, Diaz R, Castellana N, Bhattacharya I, Gerstein HC, Lakshmanan MC
Plainsboro, NJ: Novo Nordisk
Wong, M
